Cargando…

Understanding the Patient Perception of Statin Experience: A Qualitative Study

INTRODUCTION: Statin intolerance (SI) occurs in patients with dyslipidemia treated with statins. Statin-associated symptoms have been reported, but the overall patient experience is poorly understood. No instruments are available to collect this patient experience. Our aim is to develop a patient su...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vrablik, Michal, Catapano, Alberico L., Wiklund, Olov, Qian, Yi, Rane, Pratik, Grove, Alyson, Martin, Mona L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822972/ https://www.ncbi.nlm.nih.gov/pubmed/31482507 http://dx.doi.org/10.1007/s12325-019-01073-7

Ejemplares similares

Combination therapy in cholesterol reduction: focus on ezetimibe and statins
por: Grigore, Liliana, et al.
Publicado: (2008)

Understanding Statin Non-Adherence: Knowing Which Perceptions and Experiences Matter to Different Patients
por: Wouters, Hans, et al.
Publicado: (2016)

Efficacy of alirocumab according to background statin type and dose: pooled analysis of 8 ODYSSEY Phase 3 clinical trials
por: Catapano, Alberico L., et al.
Publicado: (2017)

Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
por: Mach, François, et al.
Publicado: (2018)

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
por: Stroes, Erik S., et al.
Publicado: (2015)

Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies
por: Pradelli, Danitza, et al.
Publicado: (2015)

Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration
por: Ference, Brian A, et al.
Publicado: (2018)

Pharmacodynamic effect of bempedoic acid and statin combinations: predictions from a dose–response model
por: Jadhav, Satyawan B, et al.
Publicado: (2021)

Identification and Management of Statin-Associated Symptoms in Clinical Practice: Extension of a Clinician Survey to 12 Further Countries
por: Rosenson, Robert S., et al.
Publicado: (2017)

New insights into the role of bempedoic acid and ezetimibe in the treatment of hypercholesterolemia
por: Pirillo, Angela, et al.
Publicado: (2022)

SLCO1B1 Polymorphism is not associated with Risk of Statin-Induced Myalgia/Myopathy in a Czech Population
por: Hubáček, Jaroslav A., et al.
Publicado: (2015)

Understanding Parents’ Experiences and Information Needs on Pediatric Acute Otitis Media: A Qualitative Study
por: Meherali, Salima, et al.
Publicado: (2018)

Molecular Mechanisms Responsible for the Antiinflammatory and Protective Effect of HDL on the Endothelium
por: Norata, Giuseppe D, et al.
Publicado: (2005)

Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
por: Rysz-Górzynska, Magdalena, et al.
Publicado: (2016)

Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy
por: Ballantyne, Christie M, et al.
Publicado: (2019)

Perceptions and Understandings of Frailty Language: A Scoping Review
por: Sakamoto, Mariko, et al.
Publicado: (2020)

Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related Diseases
por: Pirillo, Angela, et al.
Publicado: (2013)

Update on the management of severe hypertriglyceridemia – focus on free fatty acid forms of omega-3
por: Pirillo, Angela, et al.
Publicado: (2015)

Inclisiran: How Widely and When Should We Use It?
por: Pirillo, Angela, et al.
Publicado: (2022)

Monoclonal Antibodies in the Management of Familial Hypercholesterolemia: Focus on PCSK9 and ANGPTL3 Inhibitors
por: Pirillo, Angela, et al.
Publicado: (2021)

Pharmacogenomics of statins: understanding susceptibility to adverse effects
por: Kitzmiller, Joseph P, et al.
Publicado: (2016)

Understanding the molecular mechanisms of statin pleiotropic effects
por: German, Charles A., et al.
Publicado: (2023)

Patient-provider disconnect: A qualitative exploration of understanding and perceptions to care integration
por: Lai, Yi Feng, et al.
Publicado: (2017)

HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases
por: Bonacina, Fabrizia, et al.
Publicado: (2021)

Editorial: Rare dyslipidemias
por: Sadiq, Fouzia, et al.
Publicado: (2023)

Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical Characteristics
por: Altschmiedova, Tereza, et al.
Publicado: (2022)

Adherence to lipid-lowering treatment: the patient perspective
por: Casula, Manuela, et al.
Publicado: (2012)

Multifactorial Activation of NLRP3 Inflammasome: Relevance for a Precision Approach to Atherosclerotic Cardiovascular Risk and Disease
por: Baragetti, Andrea, et al.
Publicado: (2020)

Molecular Immune-Inflammatory Connections between Dietary Fats and Atherosclerotic Cardiovascular Disease: Which Translation into Clinics?
por: Mattavelli, Elisa, et al.
Publicado: (2021)

Nutraceuticals for Dyslipidaemia and Glucometabolic Diseases: What the Guidelines Tell Us (and Do Not Tell, Yet)
por: Casula, Manuela, et al.
Publicado: (2022)

Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part I: Genetics and Biochemical Parameters
por: Todorovova, Veronika, et al.
Publicado: (2022)

GP Trainees' perceptions and experiences of the training placement in Psychiatry - A qualitative study
por: Ahmed, Raja Adnan, et al.
Publicado: (2021)

HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role
por: Casula, Manuela, et al.
Publicado: (2021)

Antibiotic Prescription in the Community-Dwelling Elderly Population in Lombardy, Italy: A Sub-Analysis of the EDU.RE.DRUG Study
por: Galimberti, Federica, et al.
Publicado: (2022)

Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy’s first wave of the COVID-19 pandemic
por: Olmastroni, Elena, et al.
Publicado: (2022)

High-density lipoprotein revisited: biological functions and clinical relevance
por: von Eckardstein, Arnold, et al.
Publicado: (2022)

Impact of COVID-19 Pandemic on Adherence to Chronic Therapies: A Systematic Review
por: Olmastroni, Elena, et al.
Publicado: (2023)

Managing abusive experiences: a qualitative study among older adults in Sweden
por: Simmons, Johanna, et al.
Publicado: (2022)

High density lipoproteins and atherosclerosis: emerging aspects
por: Sala, Federica, et al.
Publicado: (2012)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7e452bu9gri1lnt08nj7lhjcsl